These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 24451437)

  • 1. Prior autoimmune disease and risk of monoclonal gammopathy of undetermined significance and multiple myeloma: a systematic review.
    McShane CM; Murray LJ; Landgren O; O'Rorke MA; Korde N; Kunzmann AT; Ismail MR; Anderson LA
    Cancer Epidemiol Biomarkers Prev; 2014 Feb; 23(2):332-42. PubMed ID: 24451437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study.
    Lindqvist EK; Goldin LR; Landgren O; Blimark C; Mellqvist UH; Turesson I; Wahlin A; Björkholm M; Kristinsson SY
    Blood; 2011 Dec; 118(24):6284-91. PubMed ID: 21998210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for monoclonal gammopathy of undetermined significance: a systematic review.
    Castaneda-Avila MA; Ulbricht CM; Epstein MM
    Ann Hematol; 2021 Apr; 100(4):855-863. PubMed ID: 33416902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. History of autoimmune disease is associated with impaired survival in multiple myeloma and monoclonal gammopathy of undetermined significance: a population-based study.
    Lindqvist EK; Landgren O; Lund SH; Turesson I; Hultcrantz M; Goldin L; Björkholm M; Kristinsson SY
    Ann Hematol; 2017 Feb; 96(2):261-269. PubMed ID: 27807648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune disease is associated with a lower risk of progression in monoclonal gammopathy of undetermined significance.
    Baldursdóttir TR; Löve ÞJ; Gíslason GK; Björkholm M; Mellqvist UH; Lund SH; Blimark CH; Turesson I; Hultcrantz M; Landgren O; Kristinsson SY
    Eur J Haematol; 2021 Mar; 106(3):380-388. PubMed ID: 33295006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmunity, Infections, and the Risk of Monoclonal Gammopathy of Undetermined Significance.
    Sigurbergsdóttir AÝ; Love TJ; Kristinsson SY
    Front Immunol; 2022; 13():876271. PubMed ID: 35572590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial monoclonal gammopathy of undetermined significance and multiple myeloma: epidemiology, risk factors, and biological characteristics.
    Greenberg AJ; Rajkumar SV; Vachon CM
    Blood; 2012 Jun; 119(23):5359-66. PubMed ID: 22354002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary monoclonal gammopathy of undetermined significance is frequently associated with high response rate and superior survival in patients with plasma cell dyscrasias.
    Zou D; An G; Zhu G; Wang J; Shi L; Meng H; Xu Y; Sui W; Deng S; Zhan F; Qiu L
    Biol Blood Marrow Transplant; 2014 Mar; 20(3):319-25. PubMed ID: 24296491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal Gammopathy of Undetermined Significance: Current Concepts and Future Prospects.
    Seth S; Zanwar S; Vu L; Kapoor P
    Curr Hematol Malig Rep; 2020 Apr; 15(2):45-55. PubMed ID: 32222885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Monoclonal gammopathy of undetermined significance--potential risk factor of multiple myeloma].
    Stelmach-Gołdyś A; Czarkowska-Paczek B
    Przegl Lek; 2012; 69(5):194-6. PubMed ID: 23050415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between metformin use and progression of monoclonal gammopathy of undetermined significance to multiple myeloma in US veterans with diabetes mellitus: a population-based retrospective cohort study.
    Chang SH; Luo S; O'Brian KK; Thomas TS; Colditz GA; Carlsson NP; Carson KR
    Lancet Haematol; 2015 Jan; 2(1):e30-6. PubMed ID: 26034780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple Myeloma.
    Sigurdardottir EE; Turesson I; Lund SH; Lindqvist EK; Mailankody S; Korde N; Björkholm M; Landgren O; Kristinsson SY
    JAMA Oncol; 2015 May; 1(2):168-74. PubMed ID: 26181017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders.
    Brown LM; Gridley G; Check D; Landgren O
    Blood; 2008 Apr; 111(7):3388-94. PubMed ID: 18239085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Autoimmune Diseases and Monoclonal Gammopathy of Undetermined Significance : An Analysis From a Population-Based Screening Study.
    Sverrisdottir I; Thorsteinsdottir S; Rognvaldsson S; Aspelund T; Vidarsson B; Onundarson PT; Agnarsson BA; Sigurdardottir M; Thorsteinsdóttir I; Sveinsdottir SV; Palmason R; Olafsson I; Sigurdsson F; Thordardóttir AR; Eythorsson E; Jonsson A; Palsson R; Indridason OS; Gislason GK; Olafsson A; Sigurdsson J; Steingrímsdóttir H; Einarsson Long T; Hultcrantz M; Durie BGM; Harding S; Landgren O; Kristinsson SY; Love TJ
    Ann Intern Med; 2024 Jun; 177(6):711-718. PubMed ID: 38768457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Undetermined Significance (MGUS).
    Viera S; Ludek P; Zdeněk A; Marta K; Martin Š; Sabina Š; Zdeněk K
    Klin Onkol; 2018; 31(4):270-276. PubMed ID: 30541309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune manifestations in patients with multiple myeloma and monoclonal gammopathy of undetermined significance.
    Shimanovsky A; Alvarez Argote J; Murali S; Dasanu CA
    BBA Clin; 2016 Dec; 6():12-8. PubMed ID: 27331023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal Gammopathy of Undetermined Significance After Kidney Transplantation: Single-Center Experience.
    Alfano G; Fontana F; Colaci E; Messerotti A; Bettelli F; Potenza L; Luppi M; Cappelli G
    Transplantation; 2017 Nov; 101(11):e337-e342. PubMed ID: 28731904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response comparison of multiple myeloma and monoclonal gammopathy of undetermined significance to the same anti-myeloma therapy: a retrospective cohort study.
    Campbell JP; Heaney JLJ; Pandya S; Afzal Z; Kaiser M; Owen R; Child JA; Cairns DA; Gregory W; Morgan GJ; Jackson GH; Bunce CM; Drayson MT
    Lancet Haematol; 2017 Dec; 4(12):e584-e594. PubMed ID: 29146225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial characteristics of autoimmune and hematologic disorders in 8,406 multiple myeloma patients: a population-based case-control study.
    Landgren O; Linet MS; McMaster ML; Gridley G; Hemminki K; Goldin LR
    Int J Cancer; 2006 Jun; 118(12):3095-8. PubMed ID: 16395700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.
    Naina HV; Harris S; Dispenzieri A; Cosio FG; Habermann TM; Stegall MD; Dean PG; Prieto M; Kyle RA; Rajkumar SV; Leung N
    Am J Nephrol; 2012; 35(4):365-71. PubMed ID: 22473253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.